WinstonWınston
Back
Alternative Energy Partners logo

Alternative Energy Partners

AEGY
Medical - Pharmaceuticals · Healthcare
Price
$0.00
+0.00 (+0.00%)
Market Cap
$411,180
Winston Score
Winston looking sleepy
No score yet — Winston is napping.
We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+5749.9% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 5.3M (2009) → 310.5M (2013)

Winston Score History

The full picture

Alternative Energy Partners, Inc. is a small healthcare company operating in the pharmaceutical space. Despite its name suggesting energy, the company has focused on cannabis-related and pharmaceutical product development. It targets niche medical markets and has operated as an early-stage business with limited commercial products available to customers.

The company generates little to no revenue, as reflected by its effectively zero gross and operating margins. It operates primarily in the United States and carries an extremely small market capitalization, meaning it is a micro-cap or shell-like entity with minimal financial scale. The biggest risk this company faces is its inability to generate consistent revenue or profit, which raises serious questions about its long-term survival and ability to fund operations without continuously diluting shareholders through new stock issuances.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-100.0% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+350.0% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

Research and development spending

Insider Activity

0.0%ownership

Flat

Insider ownership roughly steady over the past year

Cash Runway

~4 months

$155,108 cash & investments

Short runway — potential dilution ahead through share issuance

Cash watch

Alternative Energy Partners has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
N/A
Data not available
Profit after running costs
Operating Margin
N/A
Data not available
Return on the money invested
ROCE
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
-165.0%
Shrinking sales (-165.0% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
7/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial